St. Jude Medical Plans $30 Million Device Plant In Malaysia
This article was originally published in PharmAsia News
U.S. device maker St. Jude Medical plans a $30 million investment in Malaysia, building a large facility to serve as the basis for a manufacturing expansion. The company plans to begin on the office and plant combination this year with plans to begin operations in 2011. According to a government minister, St. Jude plans to kick off the facility by producing its cardiac rhythm management devices. The facility expects to employ about 300 Malaysians initially, but has the room to create as many as 1,000 jobs in the future. (Click here for more
You may also be interested in...
Purdue’s opioid settlement is making headlines for the size of the financial penalty. But the plan to re-imagine Purdue as a ‘public benefit company’ could have far-reaching significance for the industry – if it ever gets off the ground.
Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.
Given concerns about completing Phase III trials, advisory committee member asks whether US FDA has considered ‘the possibility of an expanded access protocol,’ but agency official points to added complexity that comes with the pathway; bioethics experts talk to the Pink Sheet about pros and cons of expanded access vs. EUA pathways.